C-peptide

Star0

DB16187InvestigationalSmall molecule

C-peptide is under investigation in clinical trial NCT00278980 (Effect of C-peptide on Diabetic Peripheral Neuropathy).

Formula / weight: C₁₂₉H₂₁₁N₃₅O₄₈ · 3020.304 g/mol (avg)
Also known as: Human c-peptide · Human proinsulin c-peptide · Insulin c-peptide · Proinsulin c-peptide · Proinsulin c-peptide (human)
Code names: NMIJ-CRM 6901A

Resolves to

Compound

UNIIO2J76Y002MCAS59112-80-0

Structure

InChIKeyVOUAQYXWVJDEQY-QENPJCQMSA-NSMILES

CC(C)C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O)C(C)C)C(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O

What you can answer from here — as of October 23, 2025

5Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of C-peptide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account